Clinical Trial Update: A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating intratumoral PF-3512676 plus local radiation in low-grade Non-Hodgkin lymphoma, including follicular/indolent B-cell subtypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• PF-3512676 (CPG 7909) (PF-3512676)

Snippet

Sponsor: Ronald Levy | Conditions: Lymphoma, Non-Hodgkin, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-14